Cleared Traditional

K922688 - EXTRA PROTECTION POLYURETHANE CONDOM

K922688 is the FDA 510(k) clearance for EXTRA PROTECTION POLYURETHANE CONDOM by Apex Medical Technologies, Inc.. It is a Class 2 Obstetrics & Gynecology device (product code MOL) cleared through the Traditional 510(k) pathway after a 1064-day FDA review.

K922688 · Apex Medical Technologies, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
1064d
Days
Class 2
Risk

K922688 is an FDA 510(k) clearance for the EXTRA PROTECTION POLYURETHANE CONDOM. Classified as Condom, Synthetic (product code MOL), Class II - Special Controls.

Submitted by Apex Medical Technologies, Inc. (San Diego, US). The FDA issued a Cleared decision on May 4, 1995 after a review of 1064 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5300 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Apex Medical Technologies, Inc. devices

Submission Details

510(k) Number K922688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1992
Decision Date May 04, 1995
Days to Decision 1064 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
904d slower than avg
Panel avg: 160d · This submission: 1064d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOL Condom, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.